Please assess the completion status of the following clinical trial:

Trial Title: Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Provision of written informed consent~* At least 6 months history of Gastroesophageal reflux disease (GERD) symptoms~* Continuous treatment with Proton Pump Inhibitor (PPI)~* Ability to read and write~Exclusion Criteria:~* Prior surgery of the upper gastrointestinal (GI) tract~* History of clinically significant diseases other than GERD~* Need for concomitant medication with drugs that may influence gastrointestinal symptoms

- Gender: ALL
- Minimum Age: 17 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).